NO831762L - Farmasoeytiske preparater. - Google Patents

Farmasoeytiske preparater.

Info

Publication number
NO831762L
NO831762L NO831762A NO831762A NO831762L NO 831762 L NO831762 L NO 831762L NO 831762 A NO831762 A NO 831762A NO 831762 A NO831762 A NO 831762A NO 831762 L NO831762 L NO 831762L
Authority
NO
Norway
Prior art keywords
fractions
extract
sesquiterpene lactone
sesquiterpene
treatment
Prior art date
Application number
NO831762A
Other languages
English (en)
Norwegian (no)
Inventor
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Original Assignee
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26282867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO831762(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edward Stewart Johnson, Peter John Hylands, Deborah Margaret Hylands filed Critical Edward Stewart Johnson
Publication of NO831762L publication Critical patent/NO831762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO831762A 1982-05-19 1983-05-18 Farmasoeytiske preparater. NO831762L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8214572 1982-05-19
GB8227062 1982-09-22

Publications (1)

Publication Number Publication Date
NO831762L true NO831762L (no) 1983-11-21

Family

ID=26282867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831762A NO831762L (no) 1982-05-19 1983-05-18 Farmasoeytiske preparater.

Country Status (13)

Country Link
US (1) US4758433A (fi)
EP (1) EP0098041B1 (fi)
KR (1) KR840004511A (fi)
AR (1) AR230008A1 (fi)
AU (1) AU564371B2 (fi)
CA (1) CA1270843A (fi)
DE (1) DE3380306D1 (fi)
DK (1) DK219083A (fi)
FI (1) FI831740A7 (fi)
GB (1) GB2124486B (fi)
IE (1) IE55766B1 (fi)
NO (1) NO831762L (fi)
NZ (1) NZ204256A (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
EP0364442B1 (en) * 1987-12-23 1993-03-03 Psoricur Ltd. Therapeutical compositions against psoriasis
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
CN1056142C (zh) * 1993-01-04 2000-09-06 昆明医学院第一附属医院 水朝阳内酯的制备方法
CA2141126A1 (en) * 1995-01-26 1996-07-27 Natalie J. Lazarowych Combinational drug for treating migraine and other illnesses
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
WO1998017292A1 (en) * 1996-10-21 1998-04-30 Morten Sloth Weidner Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
AU1573499A (en) * 1997-12-23 1999-07-19 Moser, Rene Sesquiterpene lactones specifically inhibit activation of nf-k B by preventing the degradation of IkB-alpha and IkB-beta
US6225339B1 (en) * 1998-01-29 2001-05-01 Pfizer Inc. Terpenoid lactone compounds and their production process
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US6221899B1 (en) 1999-01-15 2001-04-24 Pfizer Inc. Terpenoid lactone compounds and their production process
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
CN1319020A (zh) * 1999-06-03 2001-10-24 约翰逊及约翰逊法国消费者有限公司 抗炎症性疾病的野甘菊提取物
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
US6642243B1 (en) 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
IN188857B (fi) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
MXPA03008391A (es) * 2001-03-16 2004-11-12 Johnson & Johnson Composicion que contiene extracto de matricaria y uso de la misma.
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
EP2170324A4 (en) * 2007-06-21 2010-11-03 Puramed Bioscience Inc COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MIGRAINE HEADACHE AND ASSOCIATED SYMPTOMS
US10500182B2 (en) * 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
CN109761994B (zh) * 2019-02-28 2021-06-29 中国科学院新疆理化技术研究所 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法

Also Published As

Publication number Publication date
GB2124486B (en) 1986-07-16
DK219083D0 (da) 1983-05-17
GB8313530D0 (en) 1983-06-22
AR230008A1 (es) 1984-02-29
US4758433A (en) 1988-07-19
FI831740L (fi) 1983-11-20
EP0098041B1 (en) 1989-08-02
DE3380306D1 (en) 1989-09-07
AU1464683A (en) 1983-11-24
KR840004511A (ko) 1984-10-22
AU564371B2 (en) 1987-08-13
EP0098041A2 (en) 1984-01-11
NZ204256A (en) 1988-02-29
DK219083A (da) 1983-11-20
GB2124486A (en) 1984-02-22
FI831740A7 (fi) 1983-11-20
CA1270843A (en) 1990-06-26
EP0098041A3 (en) 1984-12-12
IE831164L (en) 1983-11-19
FI831740A0 (fi) 1983-05-18
IE55766B1 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
NO831762L (no) Farmasoeytiske preparater.
Asghari et al. Flavonoids from Salvia chloroleuca with α-amylsae and α-glucosidase inhibitory effect
Patel et al. Magnoflorine from Tinospora cordifolia stem inhibits α-glucosidase and is antiglycemic in rats
Anh et al. Antioxidative and α-glucosidase inhibitory constituents of Polyscias guilfoylei: experimental and computational assessments
López-Huerta et al. Hopane-type triterpenes from Cnidoscolus spinosus and their bioactivities
Ahmed et al. Phytochemical screening and enzymatic and antioxidant activities of Erythrina suberosa (Roxb) bark
Jiang et al. The fruits of Xanthium sibiricum Patr: A review on phytochemistry, pharmacological activities, and toxicity
CN103599145B (zh) 铁筷子提取物及其中有效成分的分离方法和所得化合物
CN104490894B (zh) 阔叶丰花草三萜化合物的制备方法及其在制备糖苷酶抑制剂药物中的应用
Xu et al. LC-MS guided isolation of gracilistones A and B, a pair of diastereomeric sesquiterpenoids with an unusual tetrahydrofuran-fused tricyclic skeleton from Acanthopanax gracilistylus and their potential anti-inflammatory activities
CN103622972A (zh) 化合物3α-Akebonolic acid的制备方法和在制备糖苷酶抑制剂药物中的应用
CN102796112B (zh) 异戊烯基黄酮化合物及其在制备胰脂肪酶抑制剂中的用途
CN107802626B (zh) 降血糖组合物及其制备方法、用途
CN108341849A (zh) 玉蕊醇类三萜化合物及其制备方法和在制药中的用途
CN116283874B (zh) 一种头花杜鹃杂萜类化合物、提取方法及应用
CN107674108B (zh) 豆甾烷型甾体类化合物在制备糖尿病或肥胖症药物中的应用
CN106265681B (zh) 一种三萜化合物在制备糖苷酶抑制剂药物中的应用
CN113425730B (zh) 三萜及其二聚体类化合物在制备治疗蛋白酪氨酸磷酸酶1b所介导疾病的药物中的用途
Liu et al. Pomolic acid and its glucopyranose ester promote apoptosis through autophagy in HT-29 colon cancer cells
CN105837592B (zh) 间苯三酚骈松香烷二萜类化合物及其制备方法和药物用途
Kristanty et al. Isolation of antioxidant and xanthine oxidase inhibitor from n-butanol extract of andaliman fruit (Zanthoxylum acanthopodium DC.).
Saifudin et al. The potent inhibitors of protein tyrosine phosphatase 1B from the fruits of Melaleuca leucadendron
CN107501367A (zh) 金圣草黄素‑7‑O‑β‑D‑葡萄糖醛酸丁酯及其提取方法和用途
CN107652347B (zh) 化合物DictyopterisinI及其在制备糖尿病或肥胖症药物中的用途
CN106957324A (zh) 倍半萜螺环内酯类化合物及其制备方法和用途